Quarterly ResultApr 29, 2026, 04:55 PM
BLCO Q1 Revenue +9.4% to $1.24B; Net Loss $(71)M; Separation Update
AI Summary
Bausch + Lomb Corp. reported a significant improvement in its Q1 2026 financial performance, with total revenues increasing 9.4% to $1,244 million and net loss attributable to the company substantially reduced to $(71) million from $(212) million year-over-year. Operating income turned positive at $33 million, up from a loss of $(83) million in the prior year period. The company also noted the ongoing evaluation by Bausch Health Companies Inc. regarding the separation of Bausch + Lomb, which may include monetization, sale, or distribution of BHC's ownership interest.
Key Highlights
- Bausch Health Companies Inc. continues to evaluate the separation of Bausch + Lomb.
- Q1 2026 total revenues increased 9.4% to $1,244 million from $1,137 million YoY.
- Q1 2026 net loss attributable to BLCO significantly reduced to $(71) million from $(212) million YoY.
- Basic and diluted loss per share improved to $(0.20) in Q1 2026 from $(0.60) YoY.
- Operating income improved to $33 million in Q1 2026 from an $(83) million loss YoY.
- Net cash provided by operating activities was $32 million in Q1 2026, up from $(25) million YoY.
- Total assets were $13,780 million as of March 31, 2026.
- Long-term debt was $5,031 million as of March 31, 2026.
Price Impact
More from BLCO